Psychedelic Sector Data Bank

The rapid growth of the psychedelics space has not been matched by the provision of accessible, curated data on matters such as the filing of patents or the progression of decriminalization and legalization initiatives.

Our Data Bank is a window into some of this formerly disparate data.

Our data have been cited in:

Psychedelic Patent Trackers

Curated by Calyx Law, our patent trackers catalogue published patents across a number of molecules, including psilocybin, DMT and MDMA.

DMT Patent Tracker

A catalogue of U.S. DMT-related patent publications. 

Access the data

MDMA Patent Tracker

A catalogue of U.S. MDMA-related patent publications. 

Access the data

LSD Patent Tracker

A catalogue of U.S. LSD-related patent publications.

Access the data

Psilocybin Patent Tracker

A catalogue of U.S. psilocybin-related patent publications. 

Access the data

Ibogaine Patent Tracker

A catalogue of U.S. ibogaine-related patents, where publicly announced.

Access the data

Ketamine Patent Tracker

A catalogue of U.S. ketamine-related patents, where publicly announced.

Access the data

5-MeO-DMT Patent Tracker

A catalogue of U.S. 5-MeO-DMT-related patent publications. 

Access the data

Looking for something else?

We might have what you’re looking for. Send us an email to discuss.